Question 1

What are the potential benefits of participating in this trial compared to my current treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy clinical trial (NCT00493636). Contact the study team or your healthcare provider for specific answers.

Question 2

What side effects should I expect from sorafenib and the chemotherapy drugs?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy clinical trial (NCT00493636). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to visit the clinic for treatment and monitoring?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy clinical trial (NCT00493636). Contact the study team or your healthcare provider for specific answers.

Question 4

What happens if I experience side effects or my condition worsens during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy clinical trial (NCT00493636). Contact the study team or your healthcare provider for specific answers.

Question 5

Can I continue any other medications I am currently taking while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy clinical trial (NCT00493636). Contact the study team or your healthcare provider for specific answers.

Question 6

What are the chances that I will receive the placebo instead of the active treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy clinical trial (NCT00493636). Contact the study team or your healthcare provider for specific answers.

What this study is about